fashion -WSS

fashion

author：knowledge 2025-09-06 06:51:19 - browse：73

Adam's take main illustration — Molly Ferguson/STAT

Have you heard the news? I’m launching a weekly email newsletter starting on March 28. It’s called Adam’s Biotech Scorecard and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

This week: A chat with Argenx CEO Tim Van Hauwermeiren, and updates on biotech PIPEs, Madrigal Pharmaceuticals, and Annovis Bio.

The Belgian drugmaker Argenx is preparing for a commercial launch this summer that will expand the use of its IgG-lowering antibody Vyvgart to patients with chronic inflammatory demyelinating polyneuropathy, or CIDP, an autoimmune nerve disorder that causes people to lose feeling and muscle strength in the arms and legs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Medical mystery: When a cough is not just a cough

WSS

5 to watch: Tech startups trying to solve health care's staffing crisis

Leading voice in opioid treatment defends methadone clinic system

Medical mystery: When a cough is not just a cough

For Medicare Advantage, Democrats want stronger protections around AI

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Leading voice in opioid treatment defends methadone clinic system

hotspot

fashion

entertainment

Hepatitis C has a cure — but many Americans still lack access to it

Private equity deals in Medicare Advantage declines

How to save PrEP access — and even expand it

How digital tools helped lower hypertension in marginalized patients

Malaria cases in Florida and Texas: Here’s what you need to know

Neuroscience’s long legacy of racism

Hollywood unions extend contract negotiations for actors

Physicians and social media: If you see something, say something?

Jerome Adams on the need for new antivirals for Covid

Readout LOUD podcast: How biotech is using artificial intelligence

leisure time

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

What should King Charles tell the public about his cancer?

Intermittent fasting comes with a heart risk? Not so fast

App could help diagnose ear infections more accurately — and at home

Wikipedia

knowledge

leisure time

entertainment